Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
84.7M
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
56M
-
Shares change
-
+1.98M
-
Total reported value, excl. options
-
$194M
-
Value change
-
+$5.62M
-
Put/Call ratio
-
1.1
-
Number of buys
-
50
-
Number of sells
-
-50
-
Price
-
$3.47
Significant Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q3 2023
128 filings reported holding STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share as of Q3 2023.
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56M shares
of 84.7M outstanding shares and own 66.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.99M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (5.88M shares), BVF INC/IL (3.35M shares), Rubric Capital Management LP (3.34M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.11M shares), VANGUARD GROUP INC (2.87M shares), FRANKLIN RESOURCES INC (2.83M shares), Verition Fund Management LLC (2.5M shares), Holocene Advisors, LP (2.13M shares), and BAILLIE GIFFORD & CO (1.87M shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.